Lisa M. Harper - 03 May 2025 Form 4 Insider Report for Torrid Holdings Inc. (CURV)

Role
Chief Executive Officer, Director
Signature
/s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Lisa Harper
Issuer symbol
CURV
Transactions as of
03 May 2025
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 21:29:00 UTC
Previous filing
31 Mar 2025
Next filing
07 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HARPER LISA M Chief Executive Officer, Director C/O TORRID HOLDINGS INC., 18501 EAST SAN JOSE AVENUE, CITY OF INDUSTRY /s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Lisa Harper 18 Mar 2026 0001200503

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CURV Common Stock Award +472,441 +9% $0.000000* 5,738,894 16 Mar 2026 Direct F1
transaction CURV Common Stock Disposed to Issuer -300,000 -5.2% $0.000000* 5,438,894 03 May 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CURV Option to purchase shares Award +1,267,606 $0.000000* 1,267,606 16 Mar 2026 Common Stock 1,267,606 $1.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, which will vest annually in substantially equal 25% installments on March 16 2027, March 16 2028, March 16 2029 and March 16 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date.
F2 The performance stock units (PSUs) previously reported as granted on May 3, 2022 were forfeited without consideration upon determination that the applicable performance conditions were not achieved. No shares of Common Stock were issued.
F3 Represents options to purchase shares that will start vesting on March 16, 2027 and become exercisable in substantially equal 25% installments on March 16, 2027, March 16, 2028, March 16, 2029 and March 16, 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date.